Provided By GlobeNewswire
Last update: Aug 1, 2025
HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the appointment of Justin Van Fleet, CPA, as Chief Financial Officer, effective August 1, 2025.
Read more at globenewswire.com1.02
+0.29 (+39.73%)
0.049
+0.02 (+100.82%)
Find more stocks in the Stock Screener